siRNA, Anti-Human ACTG2, 2'-MOE(CAT#: SIRGT03046WQ-2MOE)
The product SIRGT03046WQ-2MOE is a type of small interfering RNA (siRNA) that targets ACTG2 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTG2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| Modification | 2'-O-methoxyethyl (2'-MOE) |
| Scale | 20/50/100/200 nmole |
| NCBI RefSeq | NM_001199893.1; NM_001615.3 |
| Alternative Names | ACT; ACTA3; ACTE; ACTL3; ACTSG; VSCM |
| Related Diseases | Visceral Myopathy, Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome |
| Purification | HPLC |
